Skip to main content

BioLife Solutions, Inc.

corporate_fare Company Profile

BioLife Solutions, Inc.

BLFS·NASDAQ·Industrial Applications And Services·CIK 0000834365

We are a life sciences company that develops, manufactures, and markets bioproduction products and services. These offerings are designed to improve quality and reduce risks in biologic manufacturing, distribution, and transportation within the cell and gene therapy (CGT) industry. Our products are utilized in basic and applied research, as well as in the commercial manufacturing of biologic-based therapies. Customers use our products to maintain the health and function of biologic material during sourcing, manufacturing, and distribution. We currently operate as a single bioproduction products and services business, supporting various steps in the biologic material manufacturing and delivery process. Our portfolio includes biopreservation media and cell processing products. We possess in-house expertise in cryobiology and the broader CGT workflow. On October 6, 2025, the Company entered into a Limited Liability Company Membership Interest Purchase Agreement with Peli BioThermal LLC for the sale of all issued and outstanding limited liability company membership interests of SAVSU Cleo Technologies, LLC. This divestiture included our evo cloud-connected "smart" shipping container products, which provided passive storage and transport for temperature-sensitive biologics and pharmaceuticals. The SAVSU business is presented as a discontinued operation for all periods presented in the accompanying Consolidated Financial Statements. On April 4, 2025, pursuant to a Stock Purchase Agreement, the Company's wholly owned subsidiary, 2699979 Alberta LTD., acquired PanTHERA CryoSolutions Inc.

BioLife Solutions, Inc. (NASDAQ:BLFS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 26 items for BLFS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-06, rated 9/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 11 rated 8 or above. Recent SEC coverage for BLFS spans 8-K, 425, DEFA14A, DEFM14A.

Recent high-impact activity:

  • BioLife Solutions Completes $1.5B Acquisition by Repligen; Stock to Be Delisted
  • Shareholder Suits Target BioLife-Repligen Merger; Supplemental Proxy Disclosures Filed
  • BioLife Discloses Shareholder Lawsuits and Supplemental Proxy Disclosures Ahead of Merger Vote
  • BioLife Solutions Merger with Repligen Clears HSR Antitrust Review
  • BioLife Solutions Receives HSR Clearance for Repligen Merger

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$96.21M
Net Income
-$4.59M
Diluted EPS
-$0.10
Op. Cash Flow
$20.11M
Free Cash Flow
$10.64M
Gross Profit
$62.12M
Operating Income
-$16.6M
Cash & Equivalents
$33.04M
Total Debt
$5M
Debt / Equity
0.01×
Net Margin
-4.8%
Shares Outstanding
48.2M sh
Source: 10-K · filed 2026-04-28 · accession 0001628280-26-028012
Browse all tickers starting with B →

No longer listed

BLFS (BioLife Solutions, Inc.) is no longer listed on a major US exchange, so Wiseek no longer shows market data for this symbol. It last appeared on NASDAQ. BioLife Solutions, Inc was acquired by Repligen Corp (RGEN). The filings and coverage below remain available as an archive.

feed BLFS - Latest Insights

BLFS
Oct 06, 2026, 9:11 AM EDT
Filing Type: 8-K
Importance Score:
9
BLFS
Sep 30, 2026, 6:01 AM EDT
Filing Type: 425
Importance Score:
7
BLFS
Sep 30, 2026, 6:01 AM EDT
Filing Type: DEFA14A
Importance Score:
7
BLFS
Sep 09, 2026, 5:22 PM EDT
Filing Type: DEFA14A
Importance Score:
8
BLFS
Sep 09, 2026, 5:21 PM EDT
Filing Type: 8-K
Importance Score:
8
BLFS
Sep 04, 2026, 5:23 PM EDT
Filing Type: DEFM14A
Importance Score:
8
BLFS
Aug 06, 2026, 4:22 PM EDT
Filing Type: 10-Q
Importance Score:
8
BLFS
Aug 06, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
7
BLFS
Aug 06, 2026, 4:03 PM EDT
Source: PR Newswire
Importance Score:
8
BLFS
Jul 23, 2026, 6:21 PM EDT
Filing Type: 425
Importance Score:
9
BLFS
Jul 22, 2026, 5:17 PM EDT
Filing Type: 8-K
Importance Score:
10
BLFS
Jul 22, 2026, 6:57 AM EDT
Source: Reuters
Importance Score:
10
BLFS
Jun 26, 2026, 6:25 PM EDT
Source: Binance News
Importance Score:
9
BLFS
Jun 03, 2026, 8:13 AM EDT
Source: Wiseek News
Importance Score:
8
BLFS
Jun 03, 2026, 8:03 AM EDT
Filing Type: 8-K
Importance Score:
7
BLFS
May 22, 2026, 6:37 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
BLFS
May 21, 2026, 7:04 PM EDT
Filing Type: 144
Importance Score:
7
BLFS
May 20, 2026, 7:26 PM EDT
Filing Type: 144
Importance Score:
7
BLFS
May 19, 2026, 6:25 PM EDT
Filing Type: 144
Importance Score:
7
BLFS
May 07, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
7
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets